Influenza Virus

Submandibular mucin serves as a substrate for the viral enzyme neuraminidase, characterized by its high molecular weight glycoprotein structure. This compound exhibits key biological activities relevant to the study of viral infections, particularly in the context of influenza research. Its applications include investigating the enzymatic activity of neuraminidase and examining mucin interactions with viral pathogens.

Biotin-DADOO is a biotinylation reagent that facilitates the covalent attachment of biotin to various substrates. It acts as an amino component in the nucleophilic ring-opening reaction of epoxidized ω-double bonds, enabling the synthesis of biotinylated inhibitor derivatives. Additionally, Biotin-DADOO can be conjugated with carboxymethyl cellulose derivatives and is utilized in the development of biotin-estradiol conjugates for enzyme immunoassays. This reagent is also relevant in the study of influenza A research.

Oseltamivir is an orally active neuraminidase inhibitor targeting the influenza virus. It demonstrably inhibits various strains of influenza, including A/H3N2, A/H1N2, A/H1N1, and B, with mean IC50 values of 0.67 nM, 0.9 nM, 1.34 nM, and 13 nM, respectively. This compound is essential for studying antiviral strategies and evaluating the efficacy of flu treatments in laboratory settings.

Isonicotinic acid is a metabolite of Isoniazid, primarily involved in the pharmacological response to tuberculosis treatment. This compound has been shown to exhibit antiviral properties, particularly in inhibiting the replication of multiple subtypes of influenza A virus. It serves as a valuable research tool in studies focusing on antiviral drug development and mechanisms of action against viral infections.